Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03963804 · ClinicalTrials.gov registry record
Objective Brain Function Assessment of mTBI/Concussion
A clinical trial of Brain Injuries, Traumatic and Concussion, Brain, sponsored by BrainScope Company.
- Completed
- Registry status
- 268
- Enrollment target
- 4
- Study locations
NCT03963804 is a study of Brain Injuries, Traumatic and Concussion, Brain that has completed, run by BrainScope Company. The registered enrollment target is 268 participants, above the 243-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (10% higher). The trial reports 4 study locations across 4 states.
The verdict
NCT03963804, a study of Brain Injuries, Traumatic and Concussion, Brain, has completed, sponsored by BrainScope Company.
- COMPLETED
- Registry status
- 268 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study (Part 3) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery.
Conditions Studied
Interventions
- DEVICE BrainScope Ahead 300iP
Study Locations (4)
Arkansas
- University of Arkansas - Fayetteville
Florida
- University of Miami - Miami
Michigan
- Michigan State University - East Lansing
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03963804
The ClinicalTrials.gov registry entry for NCT03963804 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 243-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (10% higher). The listed sponsor is BrainScope Company, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which BrainScope Ahead 300iP is the first listed.
NCT03963804 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arkansas, Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT03963804 about?
NCT03963804 is a clinical study titled "Objective Brain Function Assessment of mTBI/Concussion". This study (Part 3) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery.
What is the current status of trial NCT03963804?
This trial is currently completed. The enrollment target is 268 participants. The study started on 2018-06-11. Estimated completion is 2019-03-29.
What conditions does trial NCT03963804 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic, Concussion, Brain, Concussion, Mild, Concussion, Intermediate, Concussion, Severe.
What interventions are being tested in trial NCT03963804?
The interventions under investigation include: BrainScope Ahead 300iP (DEVICE).
Who is sponsoring clinical trial NCT03963804?
This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03963804 being conducted?
This trial has 4 study locations across Arkansas, Florida, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
mTBI Identification and Monitoring Through Retinal Scanning
RECRUITING
-
Automated Robotic TCD in Traumatic Brain Injury
RECRUITING
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.